TP53 and cancer: TP53 gene mutations are the most common genetic alterations observed in sporadic human cancers [11], occurring in approximately 30–50% of all human tumors, indicating that loss of p53 activity provides a substantial advantage for cell transformation and uncontrolled proliferation [12].